Cancer robustness: tumour tactics.
Kitano
Hiroaki
H
Sony Computer Science Laboratories Inc., 3-14-13 Higashi-gotanda, Shinagwa, Tokyo 141-0022.
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002455:Cell Division; D015195:Drug Design; D004358:Drug Therapy / Q000639:trends; D025461:Feedback, Physiological / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D009154:Mutation / Q000235:genetics; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D013379:Substrate Specificity
D000970:Antineoplastic Agents